START Global directs clinical trials of novel anticancer agents using a high quality and innovative information technology infrastructure to ensure accurate and rapid accrual to clinical trials in a setting that emphasizes personalized and compassionate clinical care. START Midwest is the second US location for the program.
With centers located in the US and Spain, START global conducts the world’s largest Phase I medical oncology program – putting more than 900 patients per year on Phase I trials. Patients travel from all over the world to participate in our clinical trials program.
START consists of a team of highly trained physicians and staff with extensive experience in Phase I clinical trials research and are nationally recognized as thought leaders in cancer research and drug development.
START Midwest are Regional Leaders in Advanced, Compassionate Care for Cancer. Best of all, this world-class care is right here in Grand Rapids, making it much easier and more convenient for you to get the treatment, support and hope you need in your battle against cancer.